CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jul. 01, 2023	Jul. 02, 2022
Cash Flows From Operating Activities:
Net loss	$ (6,399)	$ (448,553)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization	7,532	11,857
Amortization of deferred debt issuance costs	2,719	3,526
Amortization and impairment of operating lease right of use assets	8,174	8,402
Non-cash share-based compensation	5,027	10,596
Goodwill impairment		470,207
Loss (gain) on disposal or impairment of licenses, property and equipment, and software	381	(293)
Fair value adjustments on interest rate derivatives	1,738	(44,789)
Deferred income taxes	592	(89)
Changes in operating assets and liabilities, net of impact of acquisitions:
Patient accounts receivable	(16,195)	(27,701)
Prepaid expenses	1,354	(61)
Other current and long-term assets	(10,720)	5,854
Accounts payable and other accrued liabilities	(5,790)	1,232
Accrued payroll and employee benefits	16,347	(9,341)
Insurance reserves	(3,016)	4,804
Operating lease liabilities	(7,281)	(11,348)
Other current and long-term liabilities	2,514	(3,660)
Net cash used in operating activities	(3,023)	(29,357)
Cash Flows From Investing Activities:
Acquisitions of businesses, net of cash acquired		(1,206)
Proceeds from sale of businesses		460
Payment for interest rate cap		(11,725)
Purchase of certificates of need	(2,678)
Purchases of property and equipment, and software	(3,421)	(5,985)
Net cash used in investing activities	(6,099)	(18,456)
Cash Flows From Financing Activities:
Proceeds from employee stock purchase plan	945	2,278
Proceeds from securitization obligation	45,000	40,000
Repayment of securitization obligation	(25,000)	(10,000)
Proceeds from revolving credit facility	20,000	15,000
Repayments on revolving credit facility	(20,000)
Principal payments on term loans	(4,600)	(4,300)
Principal payments on notes payable	(5,125)	(4,070)
Principal payments on financing lease obligations	(378)	(363)
Settlements with interest rate swap counterparties	7,075	(3,759)
Net cash provided by financing activities	17,917	34,786
Net change in cash and cash equivalents	8,795	(13,027)
Cash and cash equivalents at beginning of period	19,217	30,490
Cash and cash equivalents at end of period	28,012	17,463
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	60,631	42,763
Cash paid for income taxes, net of refunds received	$ 158	$ 998